|
Volumn 37, Issue 9, 2005, Pages 4028-4030
|
Inhaled nitric oxide through a noninvasive ventilation device to assess reversibility of pulmonary hypertension in selecting recipients for heart transplant
|
Author keywords
[No Author keywords available]
|
Indexed keywords
NITRIC OXIDE;
VASODILATOR AGENT;
ARTIFICIAL VENTILATION;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CONTROLLED STUDY;
DIAGNOSTIC TEST;
DISEASE SEVERITY;
HEART CATHETERIZATION;
HEART OUTPUT;
HEART RIGHT VENTRICLE FAILURE;
HEART TRANSPLANTATION;
HUMAN;
LUNG ARTERY PRESSURE;
LUNG PRESSURE;
LUNG VASCULAR RESISTANCE;
POSTOPERATIVE HEMORRHAGE;
POSTOPERATIVE PERIOD;
PREOPERATIVE PERIOD;
PRIORITY JOURNAL;
PULMONARY HYPERTENSION;
RECIPIENT;
RISK FACTOR;
SYSTOLE;
VENTILATOR;
ADMINISTRATION, INHALATION;
BLOOD PRESSURE;
BRONCHODILATOR AGENTS;
HEART TRANSPLANTATION;
HUMANS;
HYPERTENSION, PULMONARY;
NITRIC OXIDE;
PATIENT SELECTION;
PREOPERATIVE CARE;
PULMONARY ARTERY;
PULMONARY CIRCULATION;
VASCULAR RESISTANCE;
VASODILATION;
|
EID: 29544432427
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2005.09.151 Document Type: Conference Paper |
Times cited : (16)
|
References (7)
|